Bioventus
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $153,208 | $132,089 | $157,900 | $138,651 |
Gross Profit | 105,666 | 89,662 | 107,485 | 92,831 |
EBITDA | 19,376 | 20,048 | 31,143 | 22,250 |
EBIT | 8,843 | 19,449 | 10,847 | |
Net Income | 33,441 | 3,113 | 14,755 | 3,155 |
Net Change In Cash | 153,208 | 132,089 | 157,900 | 138,651 |
Free Cash Flow | 18,913 | 8,359 | 37,388 | 29,625 |
Cash | 29,457 | 35,846 | 51,238 | 42,164 |
Basic Shares | 70,838 | 70,008 | 68,914 | 68,837 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $568,087 | $573,280 | $512,345 | $512,117 |
Gross Profit | 382,430 | 388,226 | 328,193 | 331,080 |
EBITDA | 99,206 | 39,221 | -23,070 | -121,606 |
EBIT | 52,195 | -10,334 | -80,435 | -177,004 |
Net Income | 22,732 | -33,542 | -156,230 | -158,704 |
Net Change In Cash | 568,087 | 573,280 | 512,345 | 512,117 |
Free Cash Flow | 71,414 | 37,789 | 7,982 | -15,015 |
Cash | 51,238 | 41,582 | 36,964 | 30,186 |
Basic Shares | 68,914 | 65,355 | 62,647 | 61,389 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.22 |
2026-03-31 | $0.15 |
2025-12-31 | $0.24 |
2025-09-30 | $0.15 |